Yoshihiro Yabe

Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.

K. Tsuda, M. Osaki, Shuntaro Sato, 2022, Bone.